Levodopa is a dopaminergic compound used as an active pharmaceutical ingredient in medications for Parkinson's disease and related conditions. It is typically formulated with a peripheral decarboxylase inhibitor to enhance its effectiveness.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 59-92-7
3-bromo-L-tyrosine
Research compound
Tolazoline hydrochloride
pharmaceutical raw material
Bethanechol chloride
pharmaceutical raw material
Metamizole sodium hydrate
pharmaceutical raw material
Atropine sulfate hydrate
pharmaceutical raw material
The international HS code for Levodopa (CAS 59-92-7) is 2922.50.
2922.50
2922 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
WTDRDQBEARUVNC-LURJTMIESA-N
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O